R&D
Targeting proteins to bring new medicines to patients with few options
In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks …
20128 items found
News
Mulvany hits the reset button at BenevolentAI
The shape of BenevolentAI following the return of co-founder Ken …
News
Refiling for cALD therapy on the cards after new data
Minoryx Therapeutics and Neuraxpharm's experimental therapy for …
News
Drug-digital dual therapy for depression starts phase 2
An experimental antidepressant in development at Gate Neurosciences …
News
Bausch + Lomb dips on rumour of failing takeover talks
Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost …
News
uniQure rockets on map to market for Huntington's therapy
uniQure says it has reached an agreement with the FDA on a pathway to …
Digital
Sponsored
Decoding prescriber behaviour: Insights from PurpleLab
Launching a new pharmaceutical product is a high-stakes endeavour. …
Sales & Marketing
Why would a healthcare agency offer sports marketing?
Healthcare marketers looking for a fresh way to engage audiences …
News
ASH: Stem cell transplant study exposes US zip-code lottery
Access to a haematopoietic stem cell transplant (HSCT) in the US …
News
ConTIPI starts rollout of pelvic organ prolapse device in US
A non-invasive medical device that could help millions of women in …
News
MSD gets first positive trial of Keytruda/Lynparza combo
MSD's efforts to combine cancer immunotherapy Keytruda with its …
News
ASH: Blenrep ups survival by 42% in multiple myeloma trial
GSK's BCMA-directed antibody-drug conjugate Blenrep reduced the risk …
Digital
How will SearchGPT impact pharma and healthcare?
The recent launch of SearchGPT by OpenAI marks the beginning of a significant shift in how information is searched and consumed for pharma and healthcare industry leaders.
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
